Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D02011 (
FAD
)
5,530
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Biological oxidation of cyclic ketones normally results in formation of the corresponding dicarboxylic acids, which are further metabolized in the cell. Rhodococcus ruber strain SC1 was isolated from an industrial wastewater bioreactor that was able to utilize
cyclododecanone
as the sole carbon source. A reverse genetic approach was used to isolate a 10-kb gene cluster containing all genes required for oxidative conversion of
cyclododecanone
to 1,12-dodecanedioic acid (DDDA). The genes required for
cyclododecanone
oxidation were only marginally similar to the analogous genes for cyclohexanone oxidation. The biochemical function of the enzymes encoded on the 10-kb gene cluster, the flavin monooxygenase, the lactone hydrolase, the alcohol dehydrogenase, and the aldehyde dehydrogenase, was determined in Escherichia coli based on the ability to convert
cyclododecanone
. Recombinant E. coli strains grown in the presence of
cyclododecanone
accumulated lauryl lactone, 12-hydroxylauric acid, and/or DDDA depending on the genes cloned. The
cyclododecanone
monooxygenase is a type 1 Baeyer-Villiger flavin monooxygenase (
FAD
as cofactor) and exhibited substrate specificity towards long-chain cyclic ketones (C11 to C15), which is different from the specificity of cyclohexanone monooxygenase favoring short-chain cyclic compounds (C5 to C7).
...
PMID:Cloning and characterization of a gene cluster for cyclododecanone oxidation in Rhodococcus ruber SC1. 1159 93